Francisco M. Sanjuan-Ortiz

Valencia, VC 46026, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry.

Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry.

Journal: Nutrients

Published: September 08, 2025

Sustained drug-free remission in giant cell arteritis.

Sustained drug-free remission in giant cell arteritis.

Journal: Rheumatology (Oxford, England)

Published: July 05, 2024

Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register.

Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register.

Journal: RMD open

Published: November 11, 2023

Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA).

Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA).

Journal: European journal of internal medicine

Published: October 02, 2023

Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis.

Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis.

Journal: European journal of internal medicine

Published: May 07, 2023

Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.

Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.

Journal: Clinical and experimental rheumatology

Published: September 27, 2022

Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.

Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.

Journal: Clinical and experimental rheumatology

Published: August 21, 2022

The impact of disease activity on health-related quality of life in patients with systemic lupus erythematosus.

The impact of disease activity on health-related quality of life in patients with systemic lupus erythematosus.

Journal: Medicina clinica

Published: January 11, 2022

Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis.

Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis.

Journal: Medicina clinica

Published: September 11, 2021

Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.

Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.

Journal: Clinical and experimental rheumatology

Published: July 17, 2021

Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients.

Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients.

Journal: Rheumatology (Oxford, England)

Published: March 29, 2021

Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice.

Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice.

Journal: The Journal of rheumatology

Published: March 12, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026